Long-term Survival after Complete Mediastinal Lymph Node Resection and Lobectomy in Patients with Bulky N2 Non-small Cell Lung Cancer

被引:5
|
作者
Sakuraba, Motoki [1 ]
Takahashi, Nobumasa [1 ]
Oh, Shiaki [1 ]
Miyasaka, Yoshikazu [1 ]
Inagaki, Tomoya [1 ]
Suzuki, Kenji [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Bunkyo Ku, Tokyo 1138421, Japan
关键词
bulky nodes; N2; non-small cell lung carcinoma; surgery; ANATOMIC BASIS; CARCINOMA; PROGNOSIS; THERAPY; SPREAD;
D O I
10.5761/atcs.oa.09.01475
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: At Juntendo University Hospital, Japan, two patients with complete resection of bulky N2 non-small cell lung cancer (NSCLC) has survived over the long term. Therefore, we decided to retrospectively study patients who also had a complete resection of the tumor including the "bulky" superior mediastinal node for the purpose of reviewing covariates that might be related to the favorable outcome. Methods: We retrospectively analyzed the relation between covariates and survival after complete lobectomy and mediastinal lymph node resection (from April 1997 to August 2007) in 15 patients with bulky N2 NSCLC, lymph nodes greater than 2 cm in short-axis diameter (bulky nodal disease) measured on preoperative chest computer tomography. Results: Of 15 patients, 5 with bulky N2 single station had survival after the resection. Univariate analysis revealed that the postoperative stage significantly affected overall survival (p = 0.0101). Single-station node involvement in bulky N2 disease was the covariate associated with overall survival (p = 0.0150) and disease free survival (p = 0.0052). Conclusions: In the complete resection of bulky N2 NSCLC in patients with lymph nodes measuring more than 2 cm in short-axis diameter, single-station node involvement suggests a favorable outcome and long-term survival, compared to patients with multi-station involvement.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 50 条
  • [21] Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer
    Tamura, Masaya
    Matsumoto, Isao
    Saito, Daisuke
    Yoshida, Shuhei
    Takata, Munehisa
    Takemura, Hirofumi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [22] Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer
    Masaya Tamura
    Isao Matsumoto
    Daisuke Saito
    Shuhei Yoshida
    Munehisa Takata
    Hirofumi Takemura
    World Journal of Surgical Oncology, 14
  • [23] Mediastinal lymph node resection in stage IA non-small cell lung cancer with small nodule: is it mandatory?
    Kim, Dong Kwan
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2276 - 2278
  • [24] Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer - Conference discussion
    Dusmet, M.
    Yildizeli
    Van Schil, P.
    Rea, F.
    Kshivets, O.
    Gebitekin, C.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 31 (01) : 102 - 102
  • [25] Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: A systematic review
    Muralidaran, Ashok
    Detterbeck, Frank C.
    Boffa, Daniel J.
    Wang, Zuoheng
    Kim, Anthony W.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 142 (05): : 1137 - 1142
  • [26] Long-term results of middle lobectomy patients operated for non-small cell lung cancer
    Sanli, Bahar Agaoglu
    Turk, Yunus
    Sirzai, Esra Yamansavci
    Yazgan, Serkan
    Ucvet, Ahmet
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2025, : 404 - 410
  • [27] Prognostic Value of Lymph Node Ratio N2 Non-Small Cell Lung Cancer Fulfilling NCCN Resection Criteria
    Zhang, S.
    Li, S.
    Yan, S.
    Huang, M.
    Yang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S171 - S172
  • [28] Long-term results after pulmonary resection in elderly patients with non-small cell lung cancer
    Kamiyoshihara, M
    Kawashima, O
    Ishikawa, S
    Morishita, Y
    JOURNAL OF CARDIOVASCULAR SURGERY, 2000, 41 (03): : 483 - 486
  • [29] Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: what is the role for surgery?
    Awan, Musaddiq
    Sharma, Neelesh
    Towe, Christopher W.
    Efird, Jimmy T.
    Machtay, Mitchell
    Biswas, Tithi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (11) : 1131 - 1144
  • [30] Treatment outcomes of lobectomy with and without mediastinal lymph node dissection in older patients with clinical N0 non-small cell lung cancer
    Fujita, Tomohiro
    Koyanagi, Akira
    Kishimoto, Koji
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2023, 31 (05): : 431 - 438